Myriad Genetics, Inc. (MYGN) short interest & options flow
NASDAQMyriad Genetics arrives at its August 4 earnings release as a stock already in freefall — down 47% in a single session on July 31 and nearly 50% on the week, following a quarterly print on July 30 that triggered a 43% one-day collapse. The wreckage from that print defines the entire setup heading into Tuesday. The stock closed at $2.86, less than half the $5.32 level at which it…
- Market cap
- $567M
- Next earnings
- 23 Feb 2027
Key data as of 9 Nov 2026

MYGN news and analysis
RSSNo long-form analysis yet for MYGN. Pulse alerts and the live data picture are available on ORTEX.
Open MYGN on ORTEX →Want the live picture for MYGN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MYGN — free to start on ORTEX.
Sign up for free →Open MYGN on ORTEX